Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other Working Capital Changes (2019 - 2025)

Biodesix's Other Working Capital Changes history spans 7 years, with the latest figure at $508000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 217.05% year-over-year to $508000.0; the TTM value through Dec 2025 reached $174000.0, down 29.84%, while the annual FY2025 figure was $174000.0, 29.84% down from the prior year.
  • Other Working Capital Changes reached $508000.0 in Q4 2025 per BDSX's latest filing, up from -$220000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.5 million in Q4 2021 to a low of -$1.5 million in Q2 2023.
  • Average Other Working Capital Changes over 5 years is -$145750.0, with a median of -$217500.0 recorded in 2025.
  • Peak YoY movement for Other Working Capital Changes: plummeted 1422.35% in 2021, then surged 320.93% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at $1.5 million in 2021, then crashed by 115.23% to -$228000.0 in 2022, then plummeted by 57.89% to -$360000.0 in 2023, then dropped by 20.56% to -$434000.0 in 2024, then soared by 217.05% to $508000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Other Working Capital Changes are $508000.0 (Q4 2025), -$220000.0 (Q3 2025), and $101000.0 (Q2 2025).